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a  b  s  t  r  a  c  t
Digital  PCR  is an  exciting  new  ﬁeld  for  molecular  analysis,  allowing  unprecedented  precision  in  the  quan-
tiﬁcation  of nucleic  acids,  as well  as  the  ﬁne  discrimination  of  rare  molecular  events  in  complex  samples.
We  here  present  a novel  technology  for  digital  PCR,  Crystal  Digital  PCRTM, which  relies  on the use  of  a
single  chip  to  partition  samples  into  2D  droplet  arrays,  which  are  then  subjected  to  thermal  cycling  and
ﬁnally  read using  a three-color  ﬂuorescence  scanning  device.  This  novel  technology  thus  allows  three-
color  multiplexing,  which  entails  a different  approach  to  data  analysis.  In the  present publication,  weeywords:
ultiplex digital PCR
rystal Digital PCR
aica
ulticolor PCR
GFR
present  this  innovative  workﬂow,  which  is both  fast  and  user-friendly,  and discuss  associated  data  anal-
ysis issue,  such  as  ﬂuorescence  spillover  compensation  and  data  representation.  Lastly,  we  also  present
proof-of-concept  of  this  three-color  detection  system,  using  a  quadriplex  assay  for  the  detection  of  EGFR
mutations  L858R,  L861Q  and T790M.
© 2016  Published  by Elsevier  GmbH.  This  is  an  open  access  article  under  the  CC BY-NC-ND  license
SCLC
. Introduction
Digital PCR has been emerging in recent years as a powerful
ew addition to the molecular biologist’s toolbox, yielding quan-
itative information of unparalleled precision about nucleic acids
1–3]. Its applications are diverse, ranging from clinical specialties
uch as oncology, for example for the genotyping and monitoring
f lung cancer, an area with high research activity [4–6], organ
ransplantation [7–9], microbiology [10–12], virology [13–15] or
on-invasive prenatal testing [16–20]; to environmental studies
21–23], or health and safety monitoring for food and feed products
24].
This technology, developed independently by different groups
n the early 90 s [25–29], was at ﬁrst technically challenging: for a
ingle sample, end-point dilutions had to be carried out in dozens of
6 or 384 well plates, making sample partitioning, the distinguish-
ng feature of digital PCR, fastidious and unpractical as a standard
ab technique. In recent years however, the availability of commer-
ial digital PCR platform has rendered possible the implementation
f digital PCR in standard biology labs, allowing proof-of-concept
r even large-scale studies to be performed for an ever increasing
ange of applications. A more in-depth account of the birth and
∗ Corresponding author.
E-mail address: magali.droniou@stilla.fr (M.E. Droniou).
1 Both authors contributed equally to the work presented in this article.
ttp://dx.doi.org/10.1016/j.bdq.2016.10.002
214-7535/© 2016 Published by Elsevier GmbH. This is an open access article under the C(http://creativecommons.org/licenses/by-nc-nd/4.0/).
development of digital PCR is related in the excellent review by A.
A. Morley [30].
In many domains, whether in biology or medicine, there is a
quest to extract as much information from a given sample, ide-
ally from a single experiment. This need for multiplex analysis
can be driven by multiple reasons: rare availability of sample, or
an effort to decrease costs of analysis for example. Hence, there
is a need in digital PCR for detecting more than one or two tar-
gets at once. Currently, most available commercial platforms only
offer two-color detection, but have developed a multiplexing strat-
egy which involves manipulating probe and primer concentrations,
in order to generate populations of different ﬂuorescence ampli-
tudes for a given detection channel [31,32]. While undoubtedly
elegant, this approach, termed amplitude-based multiplexing, may
not be entirely reliable in the presence of inhibitors, or of nucleic
acids of poor quality. These factors may  affect differently the mul-
tiple targets [33], leading to smears, displacements or fusions of
partitions populations not observed for the controls onto which
the assay was calibrated. An alternative multiplexing strategy that
ensures robustness of results is to use multiple distinct detection
channels, assign one target per detection channel and take advan-
tage of the many ﬂuorophores available for probes and/or primers.
Although partition-speciﬁc effects such as competition and dif-
ferential ampliﬁcation efﬁciencies described in [34] apply to both
amplitude-based multiplexing and multicolor multiplexing, these
effects will be more easily identiﬁed and accounted for using a
multicolor-based approach.
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The Naica SystemTM for Crystal DigitalTM PCR was developed
ith this consideration in mind. This new system relies on a three
olor detection instrument, allowing the user to perform multicolor
ultiplex digital PCR. This present paper ﬁrst presents the Naica
ystem and the Crystal Digital PCR workﬂow and then discusses
peciﬁc issues associated with multicolor digital PCR experiments:
ata representation, spillover compensation and population iden-
iﬁcation.
. Presentation of the Naica system and crystal digital PCR
orkﬂow
.1. General description
Currently available commercial digital PCR platforms rely on
wo distinct approaches. The ﬁrst to be developed was chamber
igital PCR (cdPCR), which relies on 2D arrays of microchambers
o partition the sample [35]. Once ﬁlled with the PCR mix, the
icrochambers are thermocycled on a ﬂat-block thermocycler,
hen imaged using ﬂuorescence to reveal the ampliﬁed positive
artitions. The second approach is droplet digital PCR (ddPCRTM),
n which the sample is instead partitioned in a bulk emulsion of
icrodroplets using platform-speciﬁc consumables. The emulsion
s transferred to a PCR tube or plate for thermocycling. After PCR
mpliﬁcation, data acquisition is performed in a process analogous
o ﬂow cytometry, whereby droplets are ﬂuorescently read one by
ne as they pass in front of a single laser excitation source [36].
The Naica System used herein performs digital PCR using a
ybrid approach named crystal digital PCR, combining the 2D array
ormat of cdPCR and the use of droplet partitions as implemented
n ddPCR. First, the samples are partitioned into 2D monolayer
rrays of monodisperse droplets, called droplet crystals because of
he spontaneous periodic arrangement of the droplets within the
onolayer, similarly to that of atoms within crystals. These droplet
rystals are then thermocycled on a ﬂat-block thermocycler before
eing transferred onto a ﬂuorescence microscope and imaged to
eveal the ampliﬁed partitions.
The whole process takes place inside a speciﬁcally designed
icroﬂuidic chip, the Sapphire chip shown in Fig. 1a., and requires
he use of two instruments: i) the Naica Geode, which performs the
ample partitioning and the thermal cycling of the droplet crystals,
nd ii) the Naica Prism3, an automated ﬂuorescence microscope
quipped with 3 distinct ﬂuorescence channels..2. Step1: preparing the Sapphire chips for crystal digital PCR
The Sapphire chip is an injection molded plastic microﬂuidic
hip that incorporates 4 identical microﬂuidic networks, each
ig. 1. Crystal Digital PCR Workﬂow.
. The samples are pipetted into the Sapphire chip, which is then sealed using caps. B. Th
roplets prior to thermal cycling to endpoint is started by the user. C. When thermocycling
he  Blue, Green and Red detection channels. D. Finally, data is analyzed using the Crystal M
uch  as ﬂuorescence spillover compensation, as well as the calculation of concentrations.d Quantiﬁcation 10 (2016) 34–46 35
capable of processing one sample or PCR mix. The main fea-
ture of the microﬂuidic networks is a thin rectangular chamber
(2 cm × 1 cm × 120 m)  connected in one corner to 33 droplet
production nozzles that function using conﬁnement gradients as
described in Dangla et al. [37], and are designed to produce droplets
with a diameter of 94 m,  which equates to a mean droplet volume
of 0.43 ± 0.03 nL (see Supplemental Method S2 for more details on
droplet size assessment). A distribution channel connects the 33
nozzles to the male Luer input port, while a waste channel con-
nects the opposite corner of the chamber to the male Luer outlet
port.
The Sapphire chips (Stilla Technologies) are delivered primed
with an emulsion oil containing droplet stabilizing surfactants
(Stilla Technologies, proprietary mixture), such that the entire
microﬂuidic networks and part of the ports are ﬁlled with oil. The
inlet and outlet ports of primed chips are sealed with removable
Luer caps.
To prepare the Sapphire chips, the caps are removed from the
inlet ports and 20 L of PCR mix  are pipetted into each of the 4
inlet ports. Pressure-permeable caps (Stilla Technologies) are then
positioned onto the loaded ports.
2.3. Step 2: combined partitioning and PCR ampliﬁcation using
the Naica Geode
The Naica Geode (Stilla Technologies) consists in a pressure
chamber atop a ﬂat-block thermocycler. A touch-screen user inter-
face and on-board computer allow control of both the pressure in
the chamber and the temperature of the bottom of the chamber.
2.3.1. Mechanisms of droplet generation
First, the prepared Sapphire chips are positioned onto the
ﬂat-block thermocycler and the lid of the pressure chamber is
closed tight. Then, as the combined partitioning and PCR pro-
gram is launched, the pressure within the chamber is progressively
increased to 1 bar. This overpressure is transmitted to the aque-
ous PCR mix  in the inlet port through the pressure sensitive cap,
but not directly transmitted to the outlet port which is sealed with
a solid Luer cap. This pressure imbalance thus creates a ﬂow of
the PCR mix  from the inlet port into the microﬂuidic network.
When the aqueous PCR mix  passes through the droplet injection
nozzles, it spontaneously breaks down into monodisperse droplets
which are then propelled by surface tension into the oil-ﬁlled
microﬂuidic chamber. As more and more droplets are produced,
they self-arrange into a compact hexagonal 2D monolayer.
At the same time, the ﬂow of PCR mix  into the oil-ﬁlled chamber
forces oil to ﬂow through the waste channel and into the sealed out-
let port, compressing the air remaining in the port. The ﬂow stops
e chips are then placed onto the Naica Geode, and the program that will generate
 is completed, the chips are transferred to the Naica Prism3, and images acquired for
iner software, which integrates quality control of the experiment, post-treatment
36 J. Madic et al. / Biomolecular Detection and Quantiﬁcation 10 (2016) 34–46
Table  1
Naica Prism3 detection channels speciﬁcations.
Blue Channel Green Channel Red Channel
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LExcitation range 415–480 nm 
Emission range 495–520 nm
Examples of Compatible Fluorophores FAM, AlexaFluor488 
hen pressure in the outlet port equilibrates with the overpressure
pplied in the chamber.
.3.2. Thermal cycling
The second part of the program, PCR ampliﬁcation, follows
mmediately after, according to user-deﬁned thermal cycling pro-
ram, whether for PCR or RT-PCR. The overpressure is maintained
ithin the chamber throughout the PCR cycles.
After PCR ampliﬁcation, the overpressure in the Naica Geode
s slowly decreased down to atmospheric pressure. As the over-
ressure is decreased, a pressure imbalance between the inlet and
utlet ports drives a back-ﬂow of emulsion oil into the microﬂu-
dic network. However, the conﬁnement gradients near the droplet
njection nozzles prevent the droplet crystal from ﬂowing out of
he chamber. Instead, emulsion oil ﬂows back into the inlet port
eplacing the PCR mix  that was initially deposited in the port.
After completion of the PCR program, the chips are transferred
nto the Naica Prism3 for ﬂuorescence imaging.
.4. Step 3: 3-color ﬂuorescence image acquisition and analysis of
he droplet crystal
The Naica Prism3 (Stilla Technologies) is an automated ﬂuo-
escence microscope comprising a CCD camera equipped with a
ri-band emission ﬁlter (495–520 nm//560–610 nm//655–720 nm),
 motorized x-y-z stage for sample positioning and 3 sets of
ndependently actionable high power LEDs with band pass ﬁlters
f 415–480 nm (blue channel), 530–550 nm (green channel) and
15–645 nm (red channel) for ﬂuorescence excitation. This 3-band
uorescence spectrum allows the detection of many different sets
f 3 ﬂuorophores, as illustrated in Table 1.
The Prism3 instrument acquires a set of 3 high resolution images
or each droplet crystals through the transparent bottom surface of
he Sapphire chips, with one image for each ﬂuorescence acqui-
ition channel (blue, green and red). High resolution images are
btained by stitching 15 sub-images locally acquired with the use
f the CCD camera. Exposure times for each channel can be changed
y the user (range: 0–1000 ms)  depending on assay requirements.
roplet crystals generated using the Naica system are very stable
nd can be read for up to two weeks after PCR.
able 2
ist of primers and probes.
Name Oligo Type 5’Fluorophore Sequ
ALB-Cy5P Hydrolysis probe Cy5 TGC
ALB F4 Primer – GCA
ALB R2 Primer – GGC
BRAFWTV600P Hydrolysis probe FAM CTAG
BRAF 51F Primer – TACT
BRAF  176R Primer – CCA
EGFR  L858 WT P Hydrolysis probe FAM AGT
EGFR L858R P Hydrolysis probe Cy5 AGT
EGFR L861Q P Hydrolysis probe Cy5 ACC
EGFR  L858F Primer – GCA
EGFR L858 R Primer – CCTC
EGFR T790M P Hydrolysis probe Cy3 ATG
EGFRT790M F Primer – GCC
EGFRT790M R Primer – TCTT
The + sign is a preﬁx designating a Locked Nucleic Acid (LNA) base530–550 nm 615–645 nm
560–610 nm 655–720 nm
VIC, HEX, Yakima Yellow, Cy3, ROX... Cy5, Quasar705. . .
An image analysis algorithm then identiﬁes and characterizes
each droplet in the droplet crystal to extract the ﬂuorescence inten-
sity of the droplet in each channel, its size, position, shape and
texture. The main steps in the algorithm are background subtrac-
tion, local maxima detection and watershed segmentation around
identiﬁed maxima. Artefacts such as dust particles and droplets of
inappropriate size are ﬁltered out using size, shape, texture and
position criteria in order to keep only the ﬂuorescence values of
non-coalesced droplets for data analysis. The Crystal Digital PCR
process yields between 25,000 and 30,000 analyzable droplets,
with only a few hundred droplets additionally present in the cham-
ber removed due to our quality control procedure. This equates to
a theoretical dynamic range of 5 logs, from 0.2 copies/uL to 20,000
copies/uL. It is also possible to re-analyze images acquired using
the Naica system using a customizable conﬁguration ﬁle allow-
ing advanced users to change parameters such as droplet size or
circularity values.
3. Materials and methods
3.1. DNA
Heterozygote Human genomic DNA containing the EGFR muta-
tions L858R, L861Q and T790 M were obtained from Horizon
Diagnostics (Cambridge, UK). The Universal Exogeneous qPCR Pos-
itive Control (IPC) DNA was purchased from Eurogentec (Liège,
Belgium).
Genomic DNA from Human peripheral blood mononuclear cells
(PBMC) was  extracted using QIAamp DNA Blood kit (Qiagen, Hilden,
Germany). DNA preparation purity was  assessed by absorbance
using a Nanodrop spectrophotometer (ThermoFischer, Waltham,
MA,  USA), prior to quantiﬁcation by ﬂuorescent method using the
Qubit Fluorimeter (ThermoFischer, Waltham, MA, USA). Only DNA
with absorbance ratios of A260/A280 > 1.8 and A260/A230 > 1.8 was
used in this study. All DNA were stored at −20 ◦C for less than 6
months prior to performing experiments.3.2. Oligonucleotides
Oligonucleotide primers and hydrolysis probes were syn-
thesized by Eurogentec (Liège, Belgium) in RP-HPLC-grade.
ence 3’-Quencher Reference
TGAAACATTCACCTTCCATGCA BHQ-2 [38]
TGAGAAAACGCCAGTAAGTG – [38]
AACACTCCAATACTTTCCT – [38]
CTACA + G + T + GAAATCTCG BHQ-1 [39]
GTTTTCCTTTACTTACTACACCTCAG – N/A
GACAACTGTTCAAACTGATG – N/A
TTGG + C + CA + GCCCAA BHQ-1 [6]
TTGGC + CC + GCCCAA BHQ-2 [6]
CAG + CT + GTTTGGCCA BHQ-2 N/A
GCATGTCAAGATCACAGATT – [6]
CTTCTGCATGGTATTCTTTCT – [6]
AGCT + G + CA + T + GATGAG BHQ-2 [6]
TGCTGGGCATCTG – [6]
TGTGTTCCCGGACATAGTC – [6]
J. Madic et al. / Biomolecular Detection an
Table  3
PCR mix  BRAF-IPC-ALB details.
Reagents Final concentration
PerfeCta Multiplex qPCR ToughMix 1X
FITC 40 nM
BRAF 51F 500 nM
BRAF 176R 500 nM
BRAF WTV600 P- FAM 250 nM
ALB F4 250 nM
ALB R2 250 nM
ALB P −Cy5 250 nM
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PIPC primers and YY-labelled probe 3X
ligonucleotide sequences and associated references are presented
n Table 2.
Oligonucleotides without references were designed using the
nline Primer3 design tool (http://simgene.com/Primer3).
The Universal Exogenous qPCR Positive Control DNA (IPC) was
etected using a set of primers and probe purchased from Euro-
entec (Catalog Number: RT-IPCY-B02). The IPC-speciﬁc probe
s labelled with Yakima Yellow ﬂuorophore on its 5′ end, and
uenched using TAMRA.
.3. PCR Mix
PCR reactions were carried out using PerfeCta Multiplex qPCR
oughMix (Quanta Biosciences, Gaithersburg, MD,  USA). In order to
llow adequate imaging of all droplets for software analysis, FITC
Saint Louis, MO,  USA) was added to each reaction to a ﬁnal concen-
ration of 40 nM.  Final concentrations of PCR reagents are detailed
n Tables 3 and 4.
.4. Crystal digital PCR instrument parameters
The Naica Geode was programmed to perform the sample par-
itioning step, followed by the PCR thermal cycling program: 95 ◦C
or 10 minutes, followed by 45 cycles of 95 ◦C for 10 seconds and
0 ◦C for 15 seconds.
Image acquisition was performed using the Naica Prism3 reader
sing the following exposure times: blue channel: 100 ms;  green
hannel: 50 ms;  red channel: 50 ms.
Total droplet enumeration and droplet quality control, enabled
y the detection of the reference dye FITC in the Blue channel, was
erformed by the Crystal Reader software. Extracted ﬂuorescence
alues for each droplet were then further analyzed using the Crystal
iner software (Stilla Technologies, Villejuif, France). Thresholds
ere set using the automated tool available in the Crystal Mineroftware.
able 4
CR mix EGFR Quadriplex Assay details.
Reagents Final concentration
PerfeCta Multiplex qPCR ToughMix 1X
FITC 40 nM
EGFR L858F 500 nM
EGFR L858R 500 nM
EGFR L858WT P − FAM 250 nM
EGFR L858R P − Cy5 250 nM
EGFR L861Q P − Cy5 250 nM
EGFR T790 M F 1 uM
EGFR T790 M R 1 uM
EGFR T790 M P − Cy3 250 nMd Quantiﬁcation 10 (2016) 34–46 37
3.5. Analysis and calculations
3.5.1. Determination of the limit of blank
The limits of blank (LoB) for the EGFR assays were assessed
using series of wild-type only controls (see Table S1), and recording
the number of false positive events for each of the probes detect-
ing either EGFR L858R, EGFR L861Q or EGFR T790M. A Poisson
model was  ﬁt to the data using a single parameter , representing
the mean of false positive droplets and evaluated for goodness-
of-ﬁt using the online calculator developped by H. Arsham at the
University of Baltimore (http://home.ubalt.edu/ntsbarsh/Business-
stat/otherapplets/PoissonTest.htm). Where data was  found to ﬁt a
Poisson model, the 95% upper conﬁdence limit of the Poisson dis-
tribution was  used to calculate the LoB. Where data were found not
to ﬁt a Poisson model, the limit of blank was derived from the 95%
percentile value.
3.5.2. Determination of target concentration values
In order to calculate accurate concentration values, the limit of
blank (number of false positive droplets) was  subtracted from the
number of positive droplets found for each sample assayed. The
concentration in the ﬁnal reaction mix for each sample (expressed
as copies per microliter), as well as the associated uncertainty, were
then calculated as previously described [40].
3.5.3. Determination of ratios
The ratios were expressed as a percentage of mutant sequences
amongst total DNA present. Since the EGFR L858 probe was used
to characterize concentration of wild-type DNA, the ratio for
EGFR L858R was calculated as Ratio EGFR L858R = Concentration
EGFR L858R*100/(Concentration WT  + Concentration EGFR L858R),
whereas both ratios for EGFR T790 M and EGFR L861Q used the
following equations Ratio = Concentration Mutant *100/Concentra-
tion WT.  In order to calculate theoretical ratios and associated
uncertainty, the WT and mutant stock concentration were ﬁrst
assessed by digital PCR, then diluted serially to yield a range of
ratios from 3% to 0.3%. The uncertainty associated with the ratios
was calculated as described by Whale and coworkers [40].
4. Results & discussion
4.1. Visualization of three-color experiments
4.1.1. Quality control of the analytic process
A key feature of the Naica system is the ability to access raw
data, ie the images of the droplet crystals generated by the Prism3
device, which allows the user to perform a preliminary qualita-
tive assessment of the experiment, and check that the acquisition
parameters, such as exposure times, are adequate for each channel
(Fig. 2A–C). Moreover, advanced features within the Crystal Miner
analysis software also allow users to visualize which objects have
been classiﬁed as droplets, and have been included into the anal-
ysis. This means that the user has access to the entire analytical
chain, including steps preceding the representation of extracted
ﬂuorescence data on scatterplots.
4.1.2. Graphical display
Scatterplots have proved a very useful medium to display raw
ﬂuorescence data from digital PCR experiments. These types of
graph enable the instant visual capture of various data features,
such as the segregation of partitions into populations of varying
ﬂuorescence intensities, the mean ﬂuorescence values and spread
of these populations, or the co-encapsulation of detected sequences
within partitions.
Experimental data can be represented using different types of
scatterplots. In a 1D plot, ﬂuorescence values for a given detection
38 J. Madic et al. / Biomolecular Detection and Quantiﬁcation 10 (2016) 34–46
F
D lue (A
a  taken
c C add
c
o
a
h
v
d
F
A
a
t
aig. 2. Visualization of droplet crystals.
roplet Crystal containing 29078 analyzable droplets, imaged post PCR using the B
 zoomed-in portion of the droplet crystal. Droplets in which no ampliﬁcation has
olor.  Droplets have a higher ﬂuorescent baseline in the Blue channel due to the FIT
hannel, expressed as relative ﬂuorescence units (RFU), are plotted
n the vertical axis, whereas the values displayed on the horizontal
xis represent droplet index, i.e. the order in which the droplets
ave been analyzed (Fig. 3A). These plots enable the immediate
isualization of the distribution of droplet ﬂuorescence intensities
etected for a single channel.
ig. 3. Graphical Display of three-color digital PCR experiments.
. 1D scatterplot representing droplet ﬂuorescence intensity in the Red acquisition chan
nalysis) on the x axis. B. 2-D scatterplot representing droplet ﬂuorescence intensities in 
he  Red acquisition channel on the x axis. C. 3-D scatterplot of ﬂuorescence intensities in
cquisition channel (z axis).), Green (B) and Red (C) Prism3 acquisition channels. The left insert in A. presents
 place remain dark, and droplets in which ampliﬁcation is observed are lighter in
ed to the reaction mix.
In a 2D dot plot, ﬂuorescence intensity values for one of the three
detection channels are plotted onto the vertical axis, while ﬂuores-
cence intensity values for one of the other 2 detection channels
are plotted onto the horizontal axis (Fig. 3B). The use of these 2D
scatterplots thus additionally allows the characterization of poten-
tial correlations in ﬂuorescence for the different channels. Different
nel on the y axis, and droplet index (ie a number assigned to each droplet during
the Green acquisition channel on the y axis, and droplet ﬂuorescence intensities in
 the Blue acquisition channel (x axis), Red acquisition channel (y axis) and Green
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Table  5
Signiﬁcation of the RGB additive color system used within the Naica system.
Red Channel Green Channel Blue Channel Designation Symbol
Negative Negative Negative Triple- negative (−,−,−)
Positive Negative Negative Single − positive Red (+,−,−)
Negative Positive Negative Single − positive Green (−,+,−)
Negative Negative Positive Single − positive Blue (−,−,+)
Positive Positive Negative Double-positive Red & Green (+,+,−)
Positive Negative Positive Double-positive Red & Blue (+,−,+)
Negative  Positive Positive Double-positive Green & Blue (−,+,+)
Positive Positive Positive Triple-positive (+,+,+)
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the symbol indicates the individual droplet status for each channel (R- Red, G-Gree
lue  channel, but negative in the Green channel.
echanisms underlie these correlations: co-ampliﬁcation of dif-
erent sequences in a single partition, which may  or may  not have
iological relevance; cross-reactivity of the probes with different
emplates; or ﬂuorescence spillover (see Section 4.2).
Until recently, commercially available digital PCR only offered
p to two detection channels, so a single 2D dot plot was sufﬁ-
ient to display ﬂuorescence data for a given sample. However, in
-color experiments, the output for a single chamber can be visu-
lized either as three 1D dot plots, three 2D dot plots or with a
ingle 3D dot plot (Fig. 3C). A 3D dot plot is evidently the best way
o capture all information at once for the experiment, however it is
ot an easy format to manipulate for the human eye. On the con-
rary, 1D and 2D dot plots can be more easily apprehended, and can
hus be used for further data analysis, such as threshold setting to
iscriminate negative from positive partitions.
.1.3. The RGB additive color system
In a most simple experimental setting, for each detection chan-
el, there is one negative population of droplets, in which either
mpliﬁcation and/or probe hybridization and cleavage did not
ccur, and one positive population, whose increased level of ﬂu-
rescence indicates that the aforementioned events did take place.
uch binary output means that, for n detection channels, droplets
an be categorized into 2n classes. In a two-color experiment,
roplets can thus be grouped into 4 classes: double negative, posi-
ive for channel 1 and negative for channel 2, negative for channel
 and positive for channel 2 and ﬁnally double positive; whereas
hree-color experiments imply that droplets can be categorized
nto 8 classes (Table 5).
In order to enable immediate capture of each droplet sta-
us with regard to these 8 classes on scatterplots, an additive
olor system based on the primary colors Red, Green and Blue
RGB) is used for display (Fig. 4A). This color scheme enables the
rojection of classiﬁcations in all three channels onto one- and
wo-dimensional scatterplots, thus adding depth by including con-
ributions of parameters not plotted on the axes (Fig. 4B–C). It
lso allows immediate visualization of the different populations
r clusters present for a given sample when displaying data using
 three-dimensional scatterplot (Fig. 4D).
.2. Fluorescence spillover and compensation
Fluorescence experiments using multiple ﬂuorophores are com-
only set up to detect a unique ﬂuorophore per acquisition
hannel. However, some combinations of ﬂuorochrome spectral
roperties and detection channels speciﬁcations may  result in
ore than one ﬂuorophore contributing to the signal recorded
or a given acquisition channel, a phenomenon commonly desig-
ated as ﬂuorescence spillover (also called ﬂuorescence crosstalk
r bleedthrough) [41], [42].
As described in Section 2.4., the Naica Prism3 is equipped with
hree LED for excitation and a tri-band ﬁlter for detection oflue), for example (+,−,+) indicates that a droplet is positive in both the Red and the
ﬂuorescence. The chambers are illuminated sequentially from
shorter to longer wavelengths (Blue > Green> Red LED), and each
image is acquired separately for each detection channel (Blue
image, Green image, Red Image). Illumination with a speciﬁc LED
excites ﬂuorophores whose excitation spectrum overlaps with that
of the light passing through the excitation ﬁlter. These ﬂuorophores
then re-emit light within a range of different wavelengths as ﬂuo-
rescence. Finally, only the light that passes through the tri-band
emission ﬁlter contributes to the ﬁnal image for each detection
channel (Fig. 5).
4.2.1. Identiﬁcation of ﬂuorescence spillover
In order to demonstrate the effect of ﬂuorescence spillover on
experimental data, a duplex Crystal Digital PCR experiment was
designed using two ﬂuorophores with overlapping spectral charac-
teristics, FAM, to be detected using the Blue Detection Channel, and
Yakima Yellow, to be detected using the Green Detection Channel.
As detailed in Fig. 6, there is an overlap between FAM and Yakima
Yellow excitation spectra, part of which falls within the bound-
aries of the Blue LED excitation light. Thus, it can be expected
that both ﬂuorophores will be excited upon illumination by the
Blue LED, while only Yakima Yellow will be excited upon illumi-
nation by the Green LED, and none of these ﬂuorophores will be
excited by the Red LED (Fig. 6A–C). This therefore would result
in ﬂuorescent emissions from both ﬂuorophores contributing to
the signal acquired for the Blue Detection channel, whereas only
Yakima Yellow ﬂuorescence would be detected for the Green Detec-
tion channel, and no ﬂuorescent signal detected for the Red channel
(Fig. 6A–C).
This duplex assay was developed using the FAM-labelled hydrol-
ysis probe to detect the human BRAF gene, and the Yakima
Yellow-labelled probe to hybridize to a universal exogenous qPCR
control sequence (IPC). Reactions were optimized using individual
templates, and speciﬁcity of each detection system was  con-
ﬁrmed by assaying the IPC-speciﬁc probe and primers onto human
genomic DNA, and conversely, the BRAF-speciﬁc probe and primers
onto the IPC template (data not shown). The duplex probe system
was then used to assay a mixture of the human genomic DNA and
IPC templates by Crystal Digital PCR.
We observed, as expected, two distinct populations for the
Green Detection channel, one of low ﬂuorescence intensity, cor-
responding to the droplets which did not contain any IPC, and one
of higher ﬂuorescence intensity values, corresponding to ampliﬁca-
tion and detection of the IPC template (Green positive). However, in
the Blue Detection channel, the droplets segregated into four differ-
ent populations of increasing ﬂuorescence intensity, resulting from
the ﬂuorescence spillover of the Yakima Yellow probe into the Blue
detection channel, as shown in Fig. 7.The Naica system is uniquely designed to accommodate up
to three different ﬂuorophores. In order to demonstrate the full
capacities of the Naica system, we have combined the previously
described assay, using a FAM-labelled probed targeting BRAF and a
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Fig. 4. The RGB additive system.
A.  Schematic of the color-code used by the Crystal Miner software to display droplet populations. 1-D (B), 2-D (C) and 3-D (D) scatterplots of droplets. The 8-color mode
enables the user to project the distribution of ﬂuorescence in all three channels on 1D and 2D dot plots. For example, the population with the higher ﬂuorescence values in
(B)  is composed of red (+,−,−); yellow (+,+,−); magenta (+,−,+) and pale grey (+,+,+) dots, whereas the population with lower ﬂuorescence values is composed of blue (−,−,+);
green (−,+,−); cyan (−,+,+) and dark grey (−,−,−) dots.
Fig. 5. Light path for ﬂuorescence excitation and emission within the Naica Prism3.
Samples (Droplets) are illuminated sequentially by the Blue, Green and Red LED, and re-emit light in the form of ﬂuorescence. Light emitted passes through tri-band ﬁlter to
generate the resulting image for the corresponding channel.
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Fig. 6. Spectral overlap for FAM and Yakima Yellow (YY) ﬂuorophores and its detection using the Prism3 device.
On  each graph, wavelength (nm) is plotted on the x axis, and normalized signal intensity on the y axis. A. Both FAM and Yakima Yellow contribute to the image for the Blue
detection channel. B. The image for the Green detection channel is based solely on the signal from the Yakima Yellow ﬂuorophore. C. Neither FAM, nor Yakima Yellow are
excited  by the light emitted by the Red LED, there is no signal for the Red detection channel.
Fig. 7. Identiﬁcation of additional droplet populations due to ﬂuorescence spillover.
Arrows indicate the corresponding populations in the 1D and 2D scatterplots. The sufﬁxes negative and positive designate negative and positive droplet populations
respectively for the FAM-labelled probes detecting the BRAF gene and the Yakima Yellow (YY) − labelled probe detecting the exogenous control IPC.
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Fig. 8. Spectral overlap for FAM, Yakima Yellow and Cy5 ﬂuorophores and detection using the Prism3 device.
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etection Channel. B. Both Yakima Yellow and Cy5 contribute to the image for th
hannel.
akima Yellow-labelled probe targeting IPC, with a Cy5-probe tar-
eting the human albumin (ALB) gene. The speciﬁcity of the probe
as assessed as previously described. Analysis of the spectral prop-
rties of Cy5 predicts that there may  be some ﬂuorescence spillover
nto the Green detection channel (Fig. 8).
This additional ﬂuorescence spillover of the Cy5 ﬂuorophore can
ndeed be readily observed in the Green channel, leading to the
resence of three populations of varying ﬂuorescence in the 1D dot
lot for the Green channel. Visualization of this raw data in 2D dot
lots is even more confusing since the Green versus Blue 2D dot
lots shows the segregation of the lower intensity value droplets
nto 2 populations, whereas the Blue versus Red 2D dot plot displays
 total of 8 populations, due the spillover of the Yakima Yellow
uorophore into the Blue channel (Fig. 9).
This example illustrates the impossibility to analyze raw (or
ncompensated) data, since ﬂuorescence spillover, by generating
ultiple populations of varying intensity prevents classiﬁcation of
he droplets into either negative or positive.
.2.2. Compensation for ﬂuorescence spillover
It is therefore crucial for an adequate interpretation of the
esults to correct this ﬂuorescence spillover, and this is achieved
hrough compensation. Fluorescence spillover compensation is a
ell-known feature in ﬂow cytometry analysis, where experiments
p to 12-color can be run [43].
First, the contribution of each ﬂuorophore to the ﬂuorescent sig-
al in each detection channel must be evaluated, which is achieved
hrough the use of mono-color controls, ie controls where only one
uorescent channel will have positive droplets. From these mono-
olor controls, the interferent signal in other channels can thus be
alculated, as a percentage of the ﬂuorescence intensity in the pri-
ary detection channel. Once calculated, this matrix is inverted
nd applied to the extracted ﬂuorescence values, yielding the “true”
uorophore signal, unemcumbered by spillover contribution. As a
esult, the various population clusters regain an orthogonal posi-
ioning, when viewed on a 2D dot plot (Fig. 10). For reviews on
uorescence spillover, and compensation algorithm, please refer
o [41] for additional details. on the y axis. A. Both FAM and Yakima Yellow contribute to the image for the Blue
n Detection Channel. C. Only Cy5 contributes to the image for the Red Detection
The amount of spillover is dependent on the signal intensity of
the probe, and will need to be calibrated using speciﬁc experimental
conditions (reaction efﬁciency, exposure times. . .). However, once
an assay is calibrated, the compensation matrix can be applied to
all subsequent samples using the same assay.
4.3. Droplet classiﬁcation in three-color digital PCR experiments
Once appropriate spillover compensation has been applied to
the raw ﬂuorescence data, the ﬂuorescence values displayed on
scatterplots represent the signal originating from a unique probe
for each detection channel. Thresholds or gates can therefore be
set to discriminate between positive and negative populations of
droplets and thus allow quantiﬁcation of targets.
In order to separate negative and positive droplet populations,
a simple threshold, i.e. a unique ﬂuorescence intensity value, can
be set independently for each detection channel. Such thresholds
can readily be set and displayed on either one- or two-dimensional
scatterplots, as a line with the chosen threshold value as an invari-
ant coordinate, while the other coordinate tends to inﬁnity. In a
three-dimensional setting, these thresholds then equate to two-
dimensional planes.
Droplet populations may  also be selected by gating using 2-D
geometrical shapes or free-hand drawing tools. However, caution
must be exercised during interpretation when using such tools
on multi-dimensional data. As described in Section 4.1.2., all data
from a duplex experiment can be readily displayed on a single 2-
D scatterplot to determine the single-positive and double-positive
populations for each channel. However, in a triplex experiment,
these populations are single- or double- positive only for the ref-
erential used. In fact, they represent the projection of both single
positives and double-positives, as well as both double-positives and
triple-positives onto the 2D referential. Such a selection is there-
fore not wrong, but care must be taken when interpreting data. In
order to ease visualization of contributions from the third channel,
the Naica analysis software offers an 8-color visualization mode,
using the RGB additive color system described in Section 4.1.3.
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rrows indicate the corresponding populations in the 1D and 2D scatterplots. The B
.4. Assay performance using a three-color approachOncology is one of the leading ﬁelds for application of digital
CR, addressing mainly, yet not exclusively, genotyping of cell-
ree DNA present in bodily ﬂuids, such as blood. In cases of lung
ig. 10. Correction of ﬂuorescence spillover.
 compensation matrix was derived from mono-color controls and applied to the triplex reen and Red arrows designate the different populations.
cancer speciﬁcally, tumors may  be hard to biopsy, with up to 25%
of patients suffering from advanced lung cancer not being able to
be biopsied [44].
Cell-free DNA has therefore now been accepted as a viable alter-
native to biopsy, as shown by the recent recommendation by Health
experiment in order to correct interferent ﬂuorescence.
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uthorities in the USA and Europe to allow circulating DNA to be
sed to determine the presence of absence of speciﬁc cancerous
utations, and therefore assess the therapeutic pertinence of tar-
eted therapies [45], [46].
Approximately 10-35% of patients with non-small cell lung can-
er have mutations in the epidermal Growth Factor Receptor (EGFR)
ene [47–49]. Some of these mutations may  predict response to
yrosine kinase inhibitor (TKI), and can be indicative of response to
reatment such as EGFR L858R or L861Q mutations, or resistance,
uch as EGFR T790M. Cell-free tumor DNA in the patient plasma is
ypically present in very small proportion to wild-type DNA [32].
t is therefore of the utmost importance to yield the maximum
nformation from each sample, and not split samples for analysis.
ultiplexing does allow monitoring of multiple mutations within
 single test.
In order to detect activating and resistance mutations in a sin-
le assay, a quadriplex assay was developed to detect activating
utations EGFR L858R or L861Q, using two Cy5-labelled probes, as
ell as the resistance mutation EGFR T790M using a Cy3-labelled
robe, while quantifying wild-type EGFR L858 using a FAM-labelled
robe. In order to characterize the performances of the assay, we
rst evaluated the speciﬁcity of the probes detecting the mutations
gainst wild-type DNA.
able 6
omparison of the Duplex and Multiplex EGFR Assays.
Duplex Assay
C Cmin Cmax % Mutant: 
T790  M N = 1 0.3 0 0.8 0.04 
T790 M N = 2 0.2 0 0.5 0.03 
T790 M N = 3 0.3 0 0.7 0.05 
L861Q N = 1 0.6 0.1 1.1 0.07 
L861Q N = 2 0.3 0 0.6 0.03 
L861Q N = 3 0.1 0 0.3 0.01 
L858R N = 1 0.1 0 0.3 0.02 
L858R N = 2 0.1 0 0.3 0.02 
L858R N = 3 0.1 0 0.3 0.02 
: Concentration of sample in copies per microliter. Cmin and Cmax respectively designaassay performance.
This preliminary characterization allowed us to calculate a limit
of blank (LoB), deﬁned as the number of events measured where no
mutations are present, i.e. the false positive rate (results available
in Table S1, please see Section 2.5.1 for details on calculations). The
assays were then characterized by testing serial dilutions of refer-
ence DNA carrying the EGFR L858R, L861Q or the T790 M mutations
in a background of control DNA at a ﬁnal concentration of 500
copies/uL, at ratios varying from 0.03% to 3% (Fig. 11). A regres-
sion curve was then ﬁtted to the observed values and showed good
linearity of the data (R2 values>0.9). Moreover, theoretical values
and associated uncertainties, representing quantiﬁcation of ratios
in an ideal digital PCR system, were also plotted. As can be observed
in Fig. 11A–C, there is excellent correlation between “ideal” and
observed values for each probe within this quadriplex assay.
Human genomic DNA bearing either EGFR L858R (A), L861Q
(B) or T790 M (C) mutations were serially diluted in a background
of 500 copies/microliter of wild-type human genomic DNA. The
resulting DNA mixtures were used to calibrate the EGFR quadriplex
assay performance using Crystal Digital PCR.To verify that multiplexing does not come at the cost of sensi-
tivity, we also set up duplex assays, in which each probe detecting
one of the three mutations was  assayed in association with the
probe detecting the wild-type EGFR. As shown in Table 6, both
Multiplex Assay
WT C Cmin Cmax % Mutant: WT
0.2 0 0.5 0.03
0.2 0 0.6 0.03
0.4 0 0.8 0.07
0.3 0 0.6 0.05
0.2 0 0.4 0.03
0.1 0 0.2 0.02
0.6 0 1.2 0.08
0.4 0 0.9 0.05
0.1 0 0.4 0.02
te the minimum and maximum concentrations of the 95% conﬁdence interval.
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ystems show similar performances both for absolute quantiﬁca-
ion, ie the concentration of mutant alleles observed, and for the
atio of mutant alleles to wild-type.
This assay thus highlights that multiplexing does not inherently
ecrease the sensitivity of an assay
and furthermore provides an elegant demonstration of the
ower afforded by increased color capacities.
. Towards higher color-multiplexing capabilities
There is a strong case to increase even further multiplexing
apacities in digital PCR, in order to decrease costs while increasing
hroughput, while making the most of scarce samples. Additionally,
igher multiplexing would also enable more complex experiments
o be performed, for example for linkage or single cell analyses.
inally, higher multiplexing digital PCR could also be used to ensure
ata reliability by allowing the inclusion of multiple controls within
 single assay.
In this publication, we have characterized the ﬁrst three-color
igital PCR, and discussed the speciﬁc considerations, intrinsic
o this type of experiment, such as ﬂuorescence spillover, data
epresentation, and population assignation. Some of these consid-
rations can readily be extended to n-color digital PCR, for n > 3, for
xample the calibration and computing of a compensation matrix.
thers, such as data representation and population identiﬁcation,
ay  however need ad hoc developments.
Data originating from n-color experiments can be represented
y a serie of (n(n-1))/2 two-dimensional scatterplots, meaning that
ata from a 4-color experiment can be displayed using 6 2D-
catterplots, while 10 scatterplots will be needed for a 5-color
xperiment, and 21 for a 6-color experiment! While it is true
hat if the only requirement for the experiment is the absolute
uantiﬁcation of each target, regardless of co-occurrence in the
ame droplet, thresholds can easily be checked and set using one-
imensional scatterplots. However, we would still advise to verify
ppropriate ﬂuorescence spillover compensation, and lack of probe
ross-reactivity on 2-D scatterplots.
In such case, or for more complex experimental designs where
o-occurrence of signals within droplets may  need to be charac-
erized, analyzing 21 scatterplots for each sample would certainly
rove unmanageable. Thus, in order to expand to n > 3-color digi-
al PCR, and render it user-friendly (or even just usable), we  believe
wo key aspects of data analysis must be tackled: the ﬁrst regarding
he development of algorithms for automated cluster identiﬁcation
n n-dimensions, and the second on envisioning new paradigms
or the representation of n-dimensional data, this last issue having
otential applications beyond digital PCR.
unding
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